Theresa Relation1, Amara Ndumele2, Oindrila Bhattacharyya3,4, James L Fisher5, Yaming Li1, Samilia Obeng-Gyasi1, Mariam F Eskander1, Allan Tsung1, Bridget A Oppong6. 1. Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA. 2. College of Medicine, The Ohio State University, Columbus, OH, USA. 3. Department of Economics, Indiana University Purdue University, Indianapolis, IN, USA. 4. The William Tierney Center for Health Services Research, Regenstrief Institute, Inc, Indianapolis, IN, USA. 5. James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA. 6. Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA. bridget.oppong@osumc.edu.
Abstract
BACKGROUND: Studies have shown a lower receipt of treatment among minority women with non-metastatic breast cancer. Those who refuse surgery have increased disease-specific mortality, contributing to disproportionately higher breast cancer mortality in non-Hispanic black (NHB) and Hispanic women. This study aimed to assess surgery refusal in these groups, identify factors associated with surgery refusal, and characterize the association between surgery refusal and survival. METHODS: Surveillance, Epidemiology, and End Results (SEER) Program data from 2005 to 2015 for NHB and Hispanic women with a diagnosis of non-metastatic breast cancer (n = 113,987) was divided into data of those who underwent surgery and data of those who refused surgery. Sociodemographic and tumor clinical/pathologic differences were analyzed by multivariate logistic regression of predictors of surgery refusal and Cox-proportional hazard model of disease-specific mortality. RESULTS: Of 799 patients who refused surgery, 562 were NHB and 237 were Hispanic. The percentage of patients refusing surgery increased from 0.6% in 2005 to 0.9% in 2015. The women who refused surgery were more likely to be older than 81 years, less likely to be married, and more likely to be uninsured or have Medicaid. The refusers presented with more advanced disease and more frequent estrogen receptor-positivity (ER+) and progesterone receptor-positivity (PR+) subtype on histology. Breast cancer-specific mortality increased significantly with surgery omission. Surgery refusal was independently associated with NHB race. CONCLUSION: Surgery refusal among NHB and Hispanic women with potentially curable non-metastatic breast cancer is rising, especially among NHB women, women older than 60 years, single women, and women with a later stage of disease at diagnosis. Additional studies are needed to analyze qualitative data in these populations and their underlying health beliefs, communication needs, and possible use of alternative medicine.
BACKGROUND: Studies have shown a lower receipt of treatment among minority women with non-metastatic breast cancer. Those who refuse surgery have increased disease-specific mortality, contributing to disproportionately higher breast cancer mortality in non-Hispanic black (NHB) and Hispanic women. This study aimed to assess surgery refusal in these groups, identify factors associated with surgery refusal, and characterize the association between surgery refusal and survival. METHODS: Surveillance, Epidemiology, and End Results (SEER) Program data from 2005 to 2015 for NHB and Hispanic women with a diagnosis of non-metastatic breast cancer (n = 113,987) was divided into data of those who underwent surgery and data of those who refused surgery. Sociodemographic and tumor clinical/pathologic differences were analyzed by multivariate logistic regression of predictors of surgery refusal and Cox-proportional hazard model of disease-specific mortality. RESULTS: Of 799 patients who refused surgery, 562 were NHB and 237 were Hispanic. The percentage of patients refusing surgery increased from 0.6% in 2005 to 0.9% in 2015. The women who refused surgery were more likely to be older than 81 years, less likely to be married, and more likely to be uninsured or have Medicaid. The refusers presented with more advanced disease and more frequent estrogen receptor-positivity (ER+) and progesterone receptor-positivity (PR+) subtype on histology. Breast cancer-specific mortality increased significantly with surgery omission. Surgery refusal was independently associated with NHB race. CONCLUSION: Surgery refusal among NHB and Hispanic women with potentially curable non-metastatic breast cancer is rising, especially among NHB women, women older than 60 years, single women, and women with a later stage of disease at diagnosis. Additional studies are needed to analyze qualitative data in these populations and their underlying health beliefs, communication needs, and possible use of alternative medicine.
Authors: Helena M Verkooijen; Gérald M Fioretta; Elisabetta Rapiti; Hervé Bonnefoi; Georges Vlastos; John Kurtz; Peter Schaefer; André-Pascal Sappino; Hyma Schubert; Christine Bouchardy Journal: Ann Surg Date: 2005-08 Impact factor: 12.969
Authors: Joseph Rapp; Stephanie Tuminello; Naomi Alpert; Raja M Flores; Emanuela Taioli Journal: Cancer Causes Control Date: 2019-10-19 Impact factor: 2.506
Authors: David J Restrepo; Andrea Sisti; Daniel Boczar; Maria T Huayllani; Jennifer Fishe; Emmanuel Gabriel; Sarah A McLaughlin; Sanjay Bagaria; Aaron Spaulding; Brian D Rinker; Antonio J Forte Journal: Anticancer Res Date: 2019-09 Impact factor: 2.480